Economic Atlas
Companies/Cytokinetics, Incorporated
Company profile

Cytokinetics, Incorporated

NASDAQ: CYTK · Healthcare · Biotechnology
PublicHQ South San Francisco, CA · San MateoCIK 0001061983Reports USD
#361 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
59C
Revenue TTM
$105.8M
Rev growth YoY (TTM)
+450.6%
Net income (FY)
-$785.0M
Employees
673
as of 2026-08-06
Market cap
$9.8B
as of 2026-08-06

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$88.0M$88.0M2025
Net income-$785.0M-$785.0M2025
Operating income-$612.3M-$612.3M2025
Total assets$1.4B$1.4B2025
Liabilities$2.1B$2.1B2025
Equity-$659.6M-$659.6M2025

Revenue trend

FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Collaboration Revenues100%
By geography
CHINA100%
The read

What is Cytokinetics, Incorporated’s revenue?

Cytokinetics, Incorporated booked $88.0M in FY2025 revenue, growing 377% year over year — faster than 93% of Healthcare companies we track, at a -891.6% net margin.

Peers · Healthcare
Vaso Corporation68BCeriBell, Inc.49DBiodesix, Inc.57CFluent Corp.45DHarvard Bioscience, Inc.58C4Front Ventures Corp.——
Neighbors
San Mateo →
Meta Platforms, Inc.$201.0B86AGilead Sciences, Inc.$29.4B87AEquinix, Inc.$9.2B74BRobinhood Markets, Inc.$4.5B67BElectronic Arts Inc.$7.5B82B+Revolution Medicines, Inc.$053D
Key facts
CEORobert I. Blum
SectorHealthcare
IndustryBiotechnology
HeadquartersSouth San Francisco, CA
ExchangeNASDAQ: CYTK
Employees673
IPO date2004-04-26
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.